Oncotarget · 2017 · 39 citations · 24 references
MedicinePathologyUrologyMolecular OncologyNeoplasiaOncogenesBladder CancerCancer Cell SignalingCancer ProgressionCancer Stem CellsMalignant NeoplasmsUrothelial CarcinomaCancer Stem-like CellsSelf-renewalSelf-renewal BalanceSelf-renewal RegulationTumor Initiating Cells
// Ryuta Inoue 1, 2 , Yoshihiko Hirohashi 1 , Hiroshi Kitamura 3 , Sachiyo Nishida 1, 2 , Aiko Murai 1 , Akari Takaya 1 , Eri Yamamoto 1 , Masahiro Matsuki 1, 2 , Toshiaki Tanaka 2 , Terufumi Kubo 1 , Munehide Nakatsugawa 1 , Takayuki Kanaseki 1 , Tomohide Tsukahara 1 , Noriyuki Sato 1 , Naoya Masumori 2 , Toshihiko Torigoe 1 1 Department of Pathology, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo 060-8556, Japan 2 Department of Urology, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo 060-8556, Japan 3 Department of Urology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama-Shi 930-0194, Japan Correspondence to: Yoshihiko Hirohashi, email: hirohash@sapmed.ac.jp Toshihiko Torigoe, email: torigoe@sapmed.ac.jp Keywords: cancer stem-like cells, ALDH1, GRIK2, urothelial carcinoma Received: June 29, 2016 Accepted: February 20, 2017 Published: March 16, 2017 ABSTRACT Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are small sub-population of cancer cells that are endowed with higher tumor-initiating ability, self-renewal ability and differentiation ability. CSCs/CICs could be isolated as high aldehyde dehydrogenase 1 activity cells (ALDH1 high ) from various cancer samples. In this study, we isolated urothelial carcinoma CSCs/CICs as ALDH high cells and investigated the molecular aspects. ALDH1 high cells showed greater sphere-forming ability and higher tumor-initiating ability in immune-deficient mice than those of ALDH1 low cells, indicating that CSCs/CICs were enriched in ALDH1 high cells. cDNA microarray analysis revealed that an ionotropic glutamate receptor glutamate receptor, ionotropic, kainate 2 (GRIK2) was expressed in ALDH1 high cells at a higher level than that in ALDH1 low cells. GRIK2 gene knockdown by siRNAs decreased the sphere-forming ability and invasion ability, whereas GRIK2 overexpression increased the sphere-forming ability, invasion ability and tumorigenicity, indicating that GRIK2 has a role in the maintenance of CSCs/CICs. Immunohistochemical staining revealed that higher levels of GRIK2 and ALDH1 expression were related to poorer prognosis in urinary tract carcinoma cases. The findings indicate that GRIK2 has a role in the maintenance of urothelial CSCs/CICs and that GRIK2 and ALDH1 can be prognosis prediction markers for urinary tract carcinomas.
24
Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2000 · 2.3K citations · Full text
Medicine, Oncology, Pharmacology +11